Literature DB >> 3867751

Stability of anthracycline antitumour agents in infusion fluids.

J H Beijnen, H Rosing, P A de Vries, W J Underberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3867751

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN： 0279-7976


× No keyword cloud information.
  6 in total

1.  Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs.

Authors:  A A Gabizon; Y Barenholz; M Bialer
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 2.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

Review 3.  A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.

Authors:  D A Williams; J Lokich
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.

Authors:  Carey K Anders; Barbara Adamo; Olga Karginova; Allison M Deal; Sumit Rawal; David Darr; Allison Schorzman; Charlene Santos; Ryan Bash; Tal Kafri; Lisa Carey; C Ryan Miller; Charles M Perou; Norman Sharpless; William C Zamboni
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

5.  The influence of pH and temperature on the stability of N-[(piperidine)methylene]daunorubicin Hydrochloride and a comparison of the stability of daunorubicin and its four new amidine derivatives in aqueous solutions.

Authors:  Mikołaj Piekarski; Agnieszka Dołhań; Judyta Cielecka-Piontek; Przemysław Zalewski; Witold Kycler; Aleksandra Kaczmarek; Artur Firlej; Irena Oszczapowicz; Anna Jelińska
Journal:  ScientificWorldJournal       Date:  2014-02-06

6.  Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.

Authors:  A Gabizon; R Chisin; S Amselem; S Druckmann; R Cohen; D Goren; I Fromer; T Peretz; A Sulkes; Y Barenholz
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.